New therapies for neuromuscular diseases in 2018. (2019)
Attributed to:
A Programme for ALS Care in Europe (ALS-CarE)
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(18)30414-9
PubMed Identifier: 30563673
Publication URI: http://europepmc.org/abstract/MED/30563673
Type: Journal Article/Review
Volume: 18
Parent Publication: The Lancet. Neurology
Issue: 1
ISSN: 1474-4422